Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $149,550 |
| Sells | 28 | $987,925,495 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 22 May 2024 17:40 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 22 May 2024 | Sale | 6,000 | 14.7287 | 88,372 | D |
| 22 May 2024 17:40 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 21 May 2024 | Sale | 6,000 | 14.205 | 85,230 | D |
| 22 May 2024 17:40 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 20 May 2024 | Sale | 6,000 | 15.4482 | 92,689 | D |
| 03 May 2024 19:12 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 03 May 2024 | Sale | 723 | 14.1542 | 10,233 | D |
| 03 May 2024 19:12 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 02 May 2024 | Sale | 6,000 | 14.0135 | 84,081 | D |
| 03 May 2024 19:12 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 01 May 2024 | Sale | 175 | 14.0343 | 2,456 | D |
| 08 Apr 2024 16:22 | HLVX | HilleVax Inc | FRAZIER LIFE SCIENCES X, L.P. | 10% | 04 Apr 2024 | Purchase | 8,850 | 14.5 | 128,325 | D |
| 05 Apr 2024 17:48 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 05 Apr 2024 | Sale | 6,000 | 14.44 | 86,640 | D |
| 05 Apr 2024 17:48 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 04 Apr 2024 | Sale | 6,000 | 14.7075 | 88,245 | D |
| 05 Apr 2024 17:48 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 03 Apr 2024 | Sale | 6,000 | 14.9303 | 89,582 | D |
| 01 Apr 2024 16:08 | HLVX | HilleVax Inc | MCLOUGHLIN SEAN | Chief Operating Officer | 28 Mar 2024 | Purchase | 1,250 | 16.98 | 21,225 | D |
| 20 Mar 2024 18:27 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 20 Mar 2024 | Sale | 6,000 | 164,221 | 985,326,000 | D |
| 20 Mar 2024 18:27 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 19 Mar 2024 | Sale | 6,000 | 17.4153 | 104,492 | D |
| 20 Mar 2024 18:27 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 18 Mar 2024 | Sale | 6,000 | 17.6561 | 105,937 | D |
| 08 Mar 2024 18:38 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 08 Mar 2024 | Sale | 6,000 | 18.6598 | 111,959 | D |
| 08 Mar 2024 18:38 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 07 Mar 2024 | Sale | 6,000 | 18.3688 | 110,213 | D |
| 08 Mar 2024 18:38 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 06 Mar 2024 | Sale | 6,000 | 18.9501 | 113,701 | D |
| 22 Feb 2024 17:20 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 22 Feb 2024 | Sale | 6,000 | 15.052 | 90,312 | D |
| 22 Feb 2024 17:20 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 21 Feb 2024 | Sale | 6,000 | 14.9158 | 89,495 | D |
| 22 Feb 2024 17:20 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 20 Feb 2024 | Sale | 6,000 | 14.8786 | 89,272 | D |
| 14 Feb 2024 16:22 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 12 Feb 2024 | Sale | 6,000 | 15.3201 | 91,921 | D |
| 12 Feb 2024 20:06 | HLVX | HilleVax Inc | KOHLI ADITYA | Director | 08 Feb 2024 | Sale | 8,866 | 14.9315 | 132,383 | D |
| 12 Feb 2024 19:51 | HLVX | HilleVax Inc | MALTBIE SHANE | Chief Financial Officer | 08 Feb 2024 | Sale | 3,576 | 14.9315 | 53,395 | D |
| 12 Feb 2024 19:47 | HLVX | HilleVax Inc | HERSHBERG ROBERT | See Remarks | 08 Feb 2024 | Sale | 11,597 | 14.9315 | 173,161 | D |
| 12 Feb 2024 19:35 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 08 Feb 2024 | Sale | 3,933 | 14.9315 | 58,726 | D |
| 18 Dec 2023 17:34 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 15 Dec 2023 | Sale | 10,000 | 15.5 | 155,000 | D |
| 05 Dec 2023 16:52 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 04 Dec 2023 | Sale | 10,000 | 14.5 | 145,000 | D |
| 05 Dec 2023 16:52 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 01 Dec 2023 | Sale | 10,000 | 14.2 | 142,000 | D |
| 20 Nov 2023 16:53 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 17 Nov 2023 | Sale | 10,000 | 14 | 140,000 | D |
| 13 Nov 2023 17:25 | HLVX | HilleVax Inc | BORKOWSKI ASTRID | Chief Medical Officer | 08 Nov 2023 | Sale | 5,000 | 13 | 65,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)